Ebola virus disease (EVD) news, resources and funding for global health researchers
Ebola hemorrhagic fever is an acute viral disease that often leads to severe illness and death in humans and other primates. The infection typically affects multiple organs in the body and is often accompanied by hemorrhage. Once the virus has been transmitted from an animal host to a human, it can then spread through person-to-person contact.
Scientists employed and funded by NIH's National Institute of Allergy and Infectious Diseases (NIAID) have been working for decades to develop tests to diagnose Ebola virus early, therapies to treat illness caused by the virus, and vaccines to prevent infection. Because of the past outbreaks in West Africa,
NIAID's Vaccine Research Center is supporting the
development and testing of investigational vaccines. NIAID is also researching the
long-term health effects of Ebola on survivors.
Fogarty is supporting grants to plan
research training and capacity building programs focused on emerging viral epidemics in collaboration with institutions in Guinea, Liberia and Sierra Leone.
Related News and Information
Focus: Fogarty’s response to Ebola: Where are we now?
Global Health Matters, July / August 2022
Related Video
Ebola in Zaire, 1976: The Past as Prologue: As part of the CDC lecture series, "The Past as Prologue," Fogarty senior scientist emeritus Dr. Joel Breman discussed his work in Zaire in 1976. September 5, 2019
NIH News and Resources
Other US Government Resources
- U.S. Centers for Disease Control and Prevention (CDC) Ebola resources:
- United States Agency for International Development (USAID):
Other Online Resources
Updated April 4, 2024